<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This review addresses three related <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> diseases, the study of which has generated important insights in hematopoiesis, red cell biology, and immune-mediated blood cell injury </plain></SENT>
<SENT sid="1" pm="."><plain>In Section I, Dr. Young summarizes the current knowledge of acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In most patients, an autoimmune mechanism has been inferred from positive responses to nontransplant therapies and laboratory data </plain></SENT>
<SENT sid="3" pm="."><plain>Cytotoxic T cell attack, with production of type I cytokines, leads to hematopoietic stem cell destruction and ultimately <z:hpo ids='HP_0001876'>pancytopenia</z:hpo>; this underlying mechanism is similar to other human disorders of lymphocyte-mediated, tissue-specific organ destruction (<z:mp ids='MP_0002055'>diabetes</z:mp>, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>, <z:hpo ids='HP_0000554'>uveitis</z:hpo>, <z:hpo ids='HP_0002583'>colitis</z:hpo>, etc.) </plain></SENT>
<SENT sid="4" pm="."><plain>The antigen that incites disease is unknown in <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> as in other <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo>; post-<z:hpo ids='HP_0012115'>hepatitis</z:hpo> <z:mpath ids='MPATH_58'>aplasia</z:mpath> is an obvious target for virus discovery </plain></SENT>
<SENT sid="5" pm="."><plain><z:hpo ids='HP_0001915'>Aplastic anemia</z:hpo> can be effectively treated by either stem cell transplantation or immunosuppression </plain></SENT>
<SENT sid="6" pm="."><plain>Results of recent trials with antilymphocyte globulins and high dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> are reviewed </plain></SENT>
<SENT sid="7" pm="."><plain>Dr. Abkowitz discusses the diagnosis and clinical approach to patients with acquired pure red cell <z:mpath ids='MPATH_58'>aplasia</z:mpath>, both secondary and idiopathic, in Section II </plain></SENT>
<SENT sid="8" pm="."><plain>The pathophysiology of various PRCA syndromes including immunologic inhibition of red cell differentiation, <z:mp ids='MP_0001799'>viral</z:mp> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> (especially human parvovirus B19), and <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> are discussed </plain></SENT>
<SENT sid="9" pm="."><plain>An animal model of PRCA (secondary to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with feline <z:hpo ids='HP_0001909'>leukemia</z:hpo> virus [FeLV], subgroup C) is presented </plain></SENT>
<SENT sid="10" pm="."><plain>Understanding the mechanisms by which erythropoiesis is impaired provides for insights into the process of <z:mpath ids='MPATH_458'>normal</z:mpath> red cell differentiation, as well as a rational strategy for patient management </plain></SENT>
<SENT sid="11" pm="."><plain>Among the acquired cytopenias <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>) is relatively rare; however, it can pose formidable management problems </plain></SENT>
<SENT sid="12" pm="."><plain>Since its first recognition as a disease, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> has been correctly classified as a <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>; however, the frequent co-existence of other cytopenias has hinted strongly at a more complex pathogenesis </plain></SENT>
<SENT sid="13" pm="."><plain>In Section III, Dr. Luzzatto examines recent progress in this area, with special emphasis on the <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in the PIG-A gene and resulting phenotypes </plain></SENT>
<SENT sid="14" pm="."><plain>Animal models of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> and the association of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> with <z:hpo ids='HP_0005528'>bone marrow failure</z:hpo> are also reviewed </plain></SENT>
<SENT sid="15" pm="."><plain>Expansion of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> clones must reflect somatic cell selection, probably as part of an autoimmune process </plain></SENT>
<SENT sid="16" pm="."><plain>Outstanding issues in treatment are illustrated through clinical cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> </plain></SENT>
<SENT sid="17" pm="."><plain>Biologic inferences from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> may be relevant to our understanding of more common marrow failure syndromes like <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> </plain></SENT>
</text></document>